Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Diabetes & Metabolism
|
March 29, 2017
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial
B Cariou, L A Leiter, D Müller-Wieland, et al.
Diabetologia
|
December 17, 2009
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
R A DeFronzo, M A Banerji, G A Bray, et al.
Diabetes, Obesity & Metabolism
|
April 5, 2013
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
G A Bray, S R Smith, M A Banerji, et al.
Diabetes Care
|
October 17, 1998
The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors
W C Duckworth, C D Saudek, A Giobbie-Hurder, et al.
Diabetes, Obesity & Metabolism
|
October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes
S Mudaliar, R R Henry, T P Ciaraldi, et al.
JAMA
|
October 23, 1996
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group
C D Saudek, W C Duckworth, A Giobbie-Hurder, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Diabetes & Metabolism
|
March 29, 2017
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial
B Cariou, L A Leiter, D Müller-Wieland, et al.
Diabetologia
|
December 17, 2009
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study
R A DeFronzo, M A Banerji, G A Bray, et al.
Diabetes, Obesity & Metabolism
|
April 5, 2013
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
G A Bray, S R Smith, M A Banerji, et al.
Diabetes Care
|
October 17, 1998
The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors
W C Duckworth, C D Saudek, A Giobbie-Hurder, et al.
Diabetes, Obesity & Metabolism
|
October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes
S Mudaliar, R R Henry, T P Ciaraldi, et al.
JAMA
|
October 23, 1996
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group
C D Saudek, W C Duckworth, A Giobbie-Hurder, et al.
Page
of 13